Efficacy and safety of paclitaxel nano-dispersion concentrate for injection (PICN) in subjects with metastatic breast cancer: A randomized, open label, active controlled, comparative, parallel group, and multi-centric study.
Phase of Trial: Phase II/III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 04 Jun 2014 Planned End Date changed to 1 Aug 2012.
- 04 Jun 2014 Status changed from recruiting to completed.
- 30 May 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History